The Adenine Nucleotide Translocase 2, a Mitochondrial Target for Anticancer Biotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|6|894-901

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.6, 2011-06, pp. : 894-901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Adenine Nucleotide Translocase: A Central Component of the Mitochondrial Permeability Transition Pore and Key Player in Cell Death

By  

Current Medicinal Chemistry, Vol. 10, Iss. 16, 2003-08 ,pp. : 1507-1525

Bentham Science Publishers

Access to resources Recommend Favorite

The Adenine Nucleotide Translocator: A New Potential Chemotherapeutic Target

By  

Current Drug Targets, Vol. 4, Iss. 7, 2003-10 ,pp. : 517-524

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Permeability Transition as Target of Anticancer Drugs

By  

Current Pharmaceutical Design, Vol. 20, Iss. 2, 2014-01 ,pp. : 223-244

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Superoxide Dismutase: A Promising Target for New Anticancer Therapies

By  

Current Medicinal Chemistry, Vol. 11, Iss. 10, 2004-05 ,pp. : 1299-1308

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Serine Protease HtrA2/Omi as a Potential Therapeutic Target

By  

Current Drug Targets, Vol. 10, Iss. 4, 2009-04 ,pp. : 372-383

Bentham Science Publishers

Access to resources Recommend Favorite